D&D Pharmatech347850
D&D Pharmatech (347850) Equity Acquisition, Nov 12, 2026
Filing date ·
D&D Pharmatech decided to acquire 4,299,965 preferred shares of Z-Alpha Holdings, Inc., a U.S. developer of alpha-emitting radiotherapy drugs, for cash on Nove…
Sign in to read this filing in detail
Continue to the filing details and any available analysis after signing in.
Filing lists and official source links are available without signing in.